United States internet searches for “infertility” following COVID-19 vaccine misinformation

Author:

Sajjadi Nicholas B.1ORCID,Nowlin William1,Nowlin Ross1,Wenger David1,Beal John Martin2,Vassar Matt13,Hartwell Micah13ORCID

Affiliation:

1. Office of Medical Student Research, Oklahoma State University Center for Health Sciences , Tulsa , OK , USA

2. Department of Obstetrics & Gynecology , Ascension Oklahoma St. John Medical Center , Tulsa , OK , USA

3. Department of Psychiatry and Behavioral Sciences , Oklahoma State University Center for Health Sciences , Tulsa , OK , USA

Abstract

Abstract Context On December 1, 2020, Drs. Wolfgang Wodarg and Michael Yeadon petitioned to withhold emergency use authorization of the BNT162b2 messenger ribonucleic acid vaccine for coronavirus disease 2019 (COVID-19) manufactured by BioNTech and Pfizer, raising concern for female infertility risks but acknowledging the lack of evidence. The European Medicines Agency and the US Food and Drug Administration ultimately issued emergency use authorizations, but misinformation claiming that COVID-19 vaccines cause female infertility began circulating on social media, potentially influencing public perception and medical decision making among pregnant patients or those seeking to become pregnant. Objectives To determine the potential influence misinformation may have had on public interest in infertility related topics, as analyzed through internet search statistics in the US. Methods The Google Trends tool was used to analyze results for the search terms “infertility,” “infertility AND vaccine,” and “infertility AND COVID vaccine” in the US from February 4, 2020 to February 3, 2021. We applied autoregressive integrated moving average models to forecast expected values, comparing them with actual observed values. Results At peak interest (100), the forecasted relative search volumes interest for the search terms “infertility,” “infertility AND vaccine,” and “infertility AND COVID vaccine” were 45.47 (95% CI, 33.27–57.66; p<0.001), 0.88 (95% CI, 2.87–4.63; p<0.001), and 0.29 (95% CI, −2.25–2.82; p<0.001). The actual relative search volumes at peak searching represented 119.9, 11,251, and 34,900% increases, respectively, when compared with forecasted values. Conclusions COVID-19 vaccine misinformation corresponded with increased internet searches for topics related to infertility in the US. Dispelling misinformation and informing patients about the risks and benefits of COVID-19 vaccination may prevent unnecessary vaccine hesitancy or refusal, contributing to successful vaccination efforts.

Publisher

Walter de Gruyter GmbH

Subject

Complementary and alternative medicine,Complementary and Manual Therapy

Reference17 articles.

1. Wodarg, W, Scarlattilaan, D. Petition/motion for administrative/regulatory action regarding confirmation of efficacy end points and use of data in connection with the following clinical trial (s): phase III-eudract number: 2020-002641-2. corona-ausschuss.de. https://www.wodarg.com/app/download/9033912514/Wodarg_Yeadon_EMA_Petition_Pfizer_Trial_FINAL_01DEC2020_signed_with_Exhibits_geschwa%CC%88rzt.pdf?t=1606870652.

2. Gong, R, Peng, X, Kang, S, Feng, H, Huang, J, Zhang, W, et al.. Structural characterization of the fusion core in syncytin, envelope protein of human endogenous retrovirus family W. Biochem Biophys Res Commun 2005;331:1193–200. https://doi.org/10.1016/j.bbrc.2005.04.032.

3. CDC. Vaccination considerations for people who are pregnant or breastfeeding. Published February 12, 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html [Accessed 4 Mar 2021].

4. Kreis, N-N, Ritter, A, Louwen, F, Yuan, J. A message from the human placenta: structural and immunomodulatory defense against SARS-CoV-2. Cells 2020;9. https://doi.org/10.3390/cells9081777.

5. Pinho, AC. EMA recommends first COVID-19 vaccine for authorisation in the EU. Published December 21, 2020. Available from: https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu [Accessed 4 Feb 2021].

Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3